Health Care & Life Sciences » Biotechnology | ISU abxis Co. Ltd.

ISU abxis Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
8,191
11,198
9,773
2,038
5,481
Depreciation, Depletion & Amortization
2,294
2,271
2,243
2,515
2,621
Other Funds
4,934
4,514
204
305
95
Funds from Operations
5,245
4,239
3,472
2,150
1,766
Changes in Working Capital
4,852
7,252
407
2,528
1,875
Net Operating Cash Flow
10,097
11,491
3,879
378
3,641
Capital Expenditures
7,975
2,186
1,024
4,937
6,855
Sale of Fixed Assets & Businesses
-
-
18
90
3
Purchase/Sale of Investments
70
66
22,710
20,993
11,006
Net Investing Cash Flow
7,968
2,081
26,209
16,283
18,697
Issuance/Reduction of Debt, Net
22,559
2,320
14,466
10,805
1,200
Net Financing Cash Flow
27,878
2,531
24,866
10,019
26,682
Net Change in Cash
9,814
11,041
5,221
5,887
4,344
Free Cash Flow
15,669
12,853
4,670
2,026
6,469
Other Sources
550
21
94
255
314
Change in Capital Stock
386
337
39,536
1,090
27,787
Other Uses
473
-
2,659
28
1,153

About ISU abxis Co.

View Profile
Address
5th Floor, Global R&D Centre C-Dong
Seongnam-si GY 13488
Korea, Republic Of
Employees -
Website http://www.abxis.com
Updated 09/14/2018
ISU Abxis Co., Ltd. is engaged in pharmaceutical business. It operates through the following business divisions: Bio-Pharmaceutical and Other. The company was founded on March 28, 2001 and is headquartered in Seongnam-si, South Korea.